• G007-LK Tankyrase 1/2 Inhibitor: Precision in Wnt Pathway Re

  2026-06-29

  G007-LK is a highly selective tankyrase 1/2 inhibitor used in Wnt/β-catenin signaling pathway studies and APC mutation colorectal cancer research. It demonstrates nanomolar potency and robust β-catenin degradation, providing a valuable tool for dissecting oncogenic signaling mechanisms.

• Precision Targeting of BCL-XL: Strategic Insights for Transl

  2026-06-29

  This thought-leadership article explores the strategic and mechanistic underpinnings of BCL-XL inhibition in translational cancer research. Integrating recent breakthroughs on apoptotic priming in glioblastoma and the transformative potency of A-1331852, it offers actionable guidance for researchers seeking to leverage selective BCL-XL inhibitors in apoptosis assays, senolytic strategies, and combination protocols. The discussion bridges foundational biology, experimental workflows, and translational impact, while providing a critical perspective on the evolving competitive landscape and future research directions.

• Moxifloxacin: Fluoroquinolone Antibiotic for Advanced Toxici

  2026-06-28

  Moxifloxacin from APExBIO accelerates antibiotic toxicity and metabolic response studies with unmatched solubility, reproducibility, and mechanistic clarity. Discover how to optimize workflows, troubleshoot cytotoxicity assays, and leverage new structural insights for robust bench research.

• Lipid Scrambling Regulates Ferroptosis and Tumor Immune Reje

  2026-06-27

  Yang et al. elucidate the role of TMEM16F-mediated lipid scrambling as a suppressor of ferroptosis at the plasma membrane, uncovering how its disruption sensitizes cells to ferroptotic death and enhances tumor immune rejection. These findings provide mechanistic insight into the execution phase of ferroptosis and suggest new strategies for modulating cell death and immune responses in cancer research.

• Azathramycin A: Macrolide Antibiotic Workflows for TB Resear

  2026-06-26

  Azathramycin A streamlines experimental tuberculosis workflows by enabling precise ribosomal inhibition in Mycobacterium tuberculosis, making it a cornerstone for antibiotic resistance and protein synthesis studies. Its high solubility and specificity drive reproducibility in cell-based and biophysical assays, setting a new standard for antibacterial agent evaluation.

• Pulchinenoside B4 Blocks NLRP3 Inflammasome in Colitis via C

  2026-06-26

  This study uncovers how Pulchinenoside B4 (PB4) alleviates DSS-induced colitis by specifically inhibiting CD1d-dependent NLRP3 inflammasome activation in macrophages. The findings outline a new anti-inflammatory mechanism relevant for ulcerative colitis and highlight emerging targets for inflammation research.

• DiscoveryProbe Protease Inhibitor Library: Enabling Next-Gen

  2026-06-25

  Explore how the DiscoveryProbe Protease Inhibitor Library drives advanced protease inhibition research, bridging high-throughput assay needs with modern drug design. Gain unique insight into library design rigor and assay optimization.

• Cyclic Pifithrin-α Hydrobromide: Advanced p53 Inhibition in

  2026-06-25

  Explore the multifaceted potential of Cyclic Pifithrin-α hydrobromide as a p53 inhibitor in apoptosis inhibition and DNA damage studies. This article uniquely bridges p53 modulation with neuroinflammatory signaling, revealing new opportunities for experimental design in cancer and neuropathic pain research.

• ERK Inhibition Mitigates Mitochondrial Fragmentation in OGD/

  2026-06-24

  Yuan et al. (2023) reveal that suppressing ERK signaling protects neuronal cells from oxygen-glucose deprivation/reoxygenation (OGD/R) injury by downregulating autophagy and reducing mitochondrial fragmentation. This mechanistic insight highlights the ERK-Drp1/Mfn2 axis as a potential therapeutic target in cerebral ischemia-reperfusion injury.

• GSH and GSSG Assay Kit: Illuminating Redox Dynamics in Tumor

  2026-06-23

  Explore how the GSH and GSSG Assay Kit enables advanced reduced glutathione detection and oxidized glutathione measurement in hypoxia-driven tumor research. Delve beyond workflow tips to uncover deep scientific context, practical protocol guidance, and novel insights from recent immunometabolism studies.

• Tetrazolium (chloride) for Tissue Viability and Mitochondria

  2026-06-23

  Tetrazolium (chloride), or Tetrazolium Red, sets the benchmark for mitochondrial function and tissue viability assays, enabling precise quantification of cell health in ischemic injury models. This article details actionable workflows, protocol optimizations, and troubleshooting insights that elevate assay performance from bench to preclinical applications.

• Eltanexor (KPT-8602): Optimizing Nuclear Export Inhibition i

  2026-06-22

  Eltanexor (KPT-8602) empowers cancer researchers with a second-generation, oral XPO1 inhibitor that delivers potent, selective nuclear export blockade across hematological and solid tumor models. This article translates recent mechanistic breakthroughs and workflow refinements into actionable protocols and troubleshooting guidance for maximizing assay reproducibility and interpretive clarity.

• Olsalazine Sodium: Applied Workflows in Tumor and Transporte

  2026-06-22

  Olsalazine Sodium, a precision mesalamine dimer, enables advanced cancer and xenobiotic transporter research with robust protocol flexibility. This article delivers step-by-step experimental workflows, troubleshooting guidance, and translational insights derived from recent studies—empowering scientists to achieve reproducible, high-impact results in inflammation and tumor biology.

• Ribonuclease R (20 U/μL): Enriching Circular RNA for Mechani

  2026-06-21

  Ribonuclease R (RNase R) (20 U/μL) empowers selective circular RNA enrichment and RNA structure analysis for advanced cancer and immunology research. This guide details protocol enhancements and troubleshooting strategies, bridging cutting-edge reference findings with robust, reproducible workflows.

• Ademetionine (S-Adenosylmethionine): Optimizing CNS Methylat

  2026-06-20

  Unlock the full experimental potential of S-Adenosylmethionine (SAM) in neurological and epigenetic research with this bench-to-publication guide. Learn actionable workflows, troubleshooting strategies, and how APExBIO’s high-purity ademetionine enables reproducible methylation studies in complex CNS models.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page